Treating the inflamed intestinal wall locally
Treatment of the chronic inflammatory bowel disease ulcerative colitis often produces unsatisfactory results. Researchers at the University of Bern have now developed a lipid gel that is administered directly to the inflamed part of the intestine, where it remains and releases its active substance evenly. This could result in a new, targeted therapy approach with fewer side effects.
Photos 4_20231024_UniBE_Figure ©University_of_Bern_Martina_Carone:png
